Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-112 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support research that improves understanding of basic mechanisms and biomarkers of trained immunity (i.e., innate immune memory), plus the functional implications of trained immunity, related to 1) immune system development and function, 2) immunity to vaccines or natural infections, or 3) allergic diseases, autoimmunity, or rejection of organ/tissue/cell transplantation. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 25, 2024 Category: Research Source Type: funding
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-111 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support research that improves understanding of basic mechanisms and biomarkers of trained immunity (i.e., innate immune memory), plus the functional implications of trained immunity, related to 1) immune system development and function, 2) immunity to vaccines or natural infections, or 3) allergic diseases, autoimmunity, or rejection of organ/tissue/cell transplantation. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 25, 2024 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Development of Organotypic Culture Models for Transplantation Immunology Research
Notice NOT-AI-23-064 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 9, 2023 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation (HCT)
Notice NOT-HL-23-116 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 1, 2023 Category: Research Source Type: funding
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-281 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients'...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 18, 2023 Category: Research Source Type: funding
Notice of Change to RFA-HL-24-011 "The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)"
Notice NOT-HL-23-105 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 8, 2023 Category: Research Source Type: funding
Notice of Changes to RFA-HL-24-010 "The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional)"
Notice NOT-HL-23-101 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 7, 2023 Category: Research Source Type: funding
The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-24-011 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to advance hematopoietic cell transplantation (HCT) for all patients, but particularly for patients with rare and difficult to treat non-malignant blood diseases and hematological malignancies. This will be accomplished by supporting a clinical trials network to evaluate novel cell therapy (CT) and HCT approaches. A Data Coordinating Center (DCC) and core clinical sites will be supported by funds requested as part of this initiative, as well as a limited number of trials. Additional studies and trials will be...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 20, 2023 Category: Research Source Type: funding
The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional)
Funding Opportunity RFA-HL-24-010 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to advance hematopoietic cell transplantation (HCT) for all patients, but particularly for patients with rare and difficult to treat non-malignant blood diseases and hematological malignancies. This will be accomplished by supporting a clinical trials network to evaluate novel cell therapy (CT) and HCT approaches. A Data Coordinating Center (DCC) and core clinical sites will be supported by funds requested as part of this initiative, as well as a limited number of trials. Additional studies and trials will be...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 20, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1)
Notice NOT-HL-23-068 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 10, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24)
Notice NOT-HL-23-069 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 10, 2023 Category: Research Source Type: funding
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-065 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for investigator-initiated Resource-Related Research Projects (R24). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified. Under rare circumstances, this mechanism may be used to support development of a new resource to the broader scientific community of the NIAID. It is anticipated that the ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 23, 2022 Category: Research Source Type: funding
Cooperative Centers on Human Immunology (U19 Clinical Trial Optional)
Funding Opportunity RFA-AI-22-069 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to solicit applications from interdisciplinary teams to participate in the Cooperative Centers on Human Immunology (CCHI) program. The program supports mechanistic and hypothesis-testing studies to discover novel molecules, mechanisms, or regulatory pathways governing function of the human immune system in both healthy and vulnerable populations (i.e., across lifespan, organ/tissue transplant recipients, pregnant women). Studies of interest include immunity related to prevention or treatment o...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 14, 2022 Category: Research Source Type: funding
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-225 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs should address scientific areas relevant to the NIAID mission including: biology and pathogenesis of infectious microbes, including HIV; host-microbe interactions; mechanisms regulating immune system development and function across the lifespan, and in response to infectious pathogens; immune dysfunction resulting in allergy, asthma, autoimmunity, immunodeficiency, or transplant rejection; and transla...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 13, 2022 Category: Research Source Type: funding
Notice of Change to Award Information for RFA-DK-22-506 and RFA-DK-22-507, Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed)
Notice NOT-DK-22-029 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 7, 2022 Category: Research Source Type: funding
